Sign in

CIK 0001501697

  • Non-accelerated filer
  • Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273181608
Phone
+1 857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
Open-market buys, last 90 days
$11,884
in 1 filing
Open-market sales, last 90 days
$33,658
in 1 filing

Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. KIRSKE DAVID −$34K Chief Financial Officer sold 7% of stake
  2. Craig Adam R +$12K Executive Chairman 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-01-05 Ragan Paula President and CEO Sale −2,400 $7.00 $17K 277,723
2020-12-31 Cadavid Diego Chief Medical Officer Grant or award · Stock Option (right to buy) +121,500 $6.43 $781K 121,500
2020-12-23 Ragan Paula President and CEO Sale −4,800 $7.00 $34K 280,123
2020-11-30 Taveras Arthur Chief Scientific Officer Grant or award · Stock Option (right to buy) +121,150 $6.60 $800K 121,150
2020-10-20 Stewart Murray Director Grant or award · Stock Option (right to buy) +10,000 10,000
2020-10-05 Ragan Paula President and CEO Sale −1,797 $7.00 $13K 284,923
2020-10-05 Lawton Alison Frances Director Grant or award · Stock Option (right to buy) +6,854 6,854
2020-10-05 Bridger Gary Director Grant or award · Stock Option (right to buy) +30,000 30,000
2020-10-02 Ragan Paula President and CEO Sale −603 $7.00 $4K 286,720
2020-09-21 Mostafa Adam S. Chief Financial Officer Sale −10,834 $7.08 $77K 29,589
2020-09-09 Skerlj Renato Chief Scientific Officer Sale −5,834 $8.05 $47K 42,076
2020-09-09 Ragan Paula President and CEO Sale −8,840 $8.04 $71K 287,323
2020-09-09 Meisner Derek M General Counsel Sale −8,334 $8.05 $67K 16,666
2020-09-02 Ragan Paula President and CEO Sale −2,400 $7.99 $19K 296,163
2020-08-17 Mostafa Adam S. Chief Financial Officer Grant or award +16,250 40,423
2020-08-17 Skerlj Renato Chief Scientific Officer Grant or award +8,750 47,910
2020-08-17 Ragan Paula President and CEO Grant or award +44,825 298,563
2020-08-17 Meisner Derek M General Counsel Grant or award +12,500 25,000
2020-08-14 Mostafa Adam S. Chief Financial Officer Grant or award +16,250 24,173
2020-08-14 Skerlj Renato Chief Scientific Officer Grant or award +8,750 39,160

Page 11 of 25 · 490 trades